135 related articles for article (PubMed ID: 15142968)
1. Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart.
Prabhu SD
Circ Res; 2004 May; 94(9):1155-7. PubMed ID: 15142968
[No Abstract] [Full Text] [Related]
2. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and cardiac remodeling.
Passeri J; Bloch KD
Heart Fail Clin; 2005 Jul; 1(2):275-86. PubMed ID: 17386852
[No Abstract] [Full Text] [Related]
4. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
[TBL] [Abstract][Full Text] [Related]
5. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis.
Wollert KC; Drexler H
Heart Fail Rev; 2002 Oct; 7(4):317-25. PubMed ID: 12379817
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-specific overexpression of nitric oxide synthase 3: impact on left ventricular function and myocardial infarction.
Bloch KD; Janssens S
Trends Cardiovasc Med; 2005 Oct; 15(7):249-53. PubMed ID: 16226679
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase in post-ischaemic remodelling: new pathways and mechanisms.
Manoury B; Montiel V; Balligand JL
Cardiovasc Res; 2012 May; 94(2):304-15. PubMed ID: 22227153
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.
Belge C; Hammond J; Dubois-Deruy E; Manoury B; Hamelet J; Beauloye C; Markl A; Pouleur AC; Bertrand L; Esfahani H; Jnaoui K; Götz KR; Nikolaev VO; Vanderper A; Herijgers P; Lobysheva I; Iaccarino G; Hilfiker-Kleiner D; Tavernier G; Langin D; Dessy C; Balligand JL
Circulation; 2014 Jan; 129(4):451-62. PubMed ID: 24190960
[TBL] [Abstract][Full Text] [Related]
10. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
Smith RS; Agata J; Xia CF; Chao L; Chao J
Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
Chen LL; Yin H; Huang J
Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
[TBL] [Abstract][Full Text] [Related]
12. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
[TBL] [Abstract][Full Text] [Related]
13. [Nitric oxide and heart failure].
Yoshioka T; Takahashi M; Ikeda U
Nihon Rinsho; 2004 Sep; 62 Suppl 9():527-30. PubMed ID: 15506442
[No Abstract] [Full Text] [Related]
14. Two faces of nitric oxide: lessons learned from the NOS2 knockout.
Hoit BD
Circ Res; 2001 Aug; 89(4):289-91. PubMed ID: 11509442
[No Abstract] [Full Text] [Related]
15. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
[TBL] [Abstract][Full Text] [Related]
16. [Research progress of Chinese herbal drugs in regulating ventricular remodeling by the pathway of nitric oxide].
DU J; Chen CX
Zhong Xi Yi Jie He Xue Bao; 2007 Nov; 5(6):702-6. PubMed ID: 17997951
[No Abstract] [Full Text] [Related]
17. Endogenous endothelium-derived nitric oxide inhibits myocardial caspase activity: implications for treatment of end-stage heart failure.
Mital S; Barbone A; Addonizio LJ; Quaegebeur JM; Mosca RJ; Oz MC; Hintze TH
J Heart Lung Transplant; 2002 May; 21(5):576-85. PubMed ID: 11983548
[TBL] [Abstract][Full Text] [Related]
18. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
[TBL] [Abstract][Full Text] [Related]
19. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Li HL; Zhuo ML; Wang D; Wang AB; Cai H; Sun LH; Yang Q; Huang Y; Wei YS; Liu PP; Liu DP; Liang CC
Circulation; 2007 Apr; 115(14):1885-94. PubMed ID: 17389268
[TBL] [Abstract][Full Text] [Related]
20. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.
Jiang DS; Li L; Huang L; Gong J; Xia H; Liu X; Wan N; Wei X; Zhu X; Chen Y; Chen X; Zhang XD; Li H
Hypertension; 2014 Jul; 64(1):77-86. PubMed ID: 24732887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
